Recently, metal halide perovskite solar cells (PSCs) of the general formular ABX₃ where A is a monovalent cation, that is, methylammonium (MA) CH₃NH₃+•, formamidinium CH₂(NH₂)₂⁺, Cs⁺, or Rb⁺, B stands for Pb(II) or Sn(II), and X for iodide or bromide have achieved solar to electric power conversion efficiencies (PCEs) above 22%, exceeding the efficiency of the present market leader polycrystalline silicon while using 1000 times less light harvesting material and simple solution processing for their fabrication. The top performing devices all employ formulations containing a mixture of up to four A cations and iodide as well as a small fraction of bromide as anion, whose emergence will be described in this Commentary. Apart from leading the current PV efficiency race, these new perovskite materials exhibit intense electroluminescence and an extraordinarily high stability under heat and light stress.
No takes yet. Share an insight, caveat, or question.
Michaël Grätzel (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: